I et 3 måneders studie med 302 patienter med mildt, stabilt hjertesvigt, som alle var i standardbehandling for stabilt hjertesvigt, blev tillæg af aliskiren 150 mg godt tolereret.
In a 3-month study of 302 patients with mild stable heart failure, all of whom were receiving standard therapy for stable heart failure, addition of aliskiren 150 mg was well tolerated.